NASDAQ
Crinetics Pharmaceuticals, Inc. (CRNX) has a current ratio of 12.32x as of Monday, May 25, 2026. This represents a 29.70% decrease compared to its 12-month average of 17.53x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.